Global Dermatology Drug Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Dermatology Drug Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.

According to APO Research, The global Dermatology Drug market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Dermatology Drug include AbbVie, Johnson & Johnson, Bayer, Galderma, Bristol-Myers Squibb, Novartis, Pfizer, Merz Pharma and Valeant, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dermatology Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatology Drug.
The Dermatology Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dermatology Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

AbbVie
Johnson & Johnson
Bayer
Galderma
Bristol-Myers Squibb
Novartis
Pfizer
Merz Pharma
Valeant
LEO Pharma
GlaxoSmithKline
Dermatology Drug segment by Type

External Use
Oral
Injection
Dermatology Drug segment by Application

Psoriasis
Skin Infections
Acne
Dermatitis
Others
Dermatology Drug Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dermatology Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dermatology Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dermatology Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Dermatology Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Dermatology Drug Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Dermatology Drug Market Size by Region (2019-2030)
1.4.1 Global Dermatology Drug Market Size by Region (2019-2024)
1.4.2 Global Dermatology Drug Market Size by Region (2025-2030)
1.5 Key Regions Dermatology Drug Market Size (2019-2030)
1.5.1 North America Dermatology Drug Market Size Growth Rate (2019-2030)
1.5.2 Europe Dermatology Drug Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Dermatology Drug Market Size Growth Rate (2019-2030)
1.5.4 Latin America Dermatology Drug Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Dermatology Drug Market Size Growth Rate (2019-2030)
2 Dermatology Drug Market by Type
2.1 Type Introduction
2.1.1 External Use
2.1.2 Oral
2.1.3 Injection
2.2 Global Dermatology Drug Market Size by Type
2.2.1 Global Dermatology Drug Market Size Overview by Type (2019-2030)
2.2.2 Global Dermatology Drug Historic Market Size Review by Type (2019-2024)
2.2.3 Global Dermatology Drug Market Size Forecasted by Type (2025-2030)
2.3 Global Dermatology Drug Market Size by Regions
2.3.1 North America Dermatology Drug Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Dermatology Drug Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Dermatology Drug Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Dermatology Drug Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Dermatology Drug Market Size Breakdown by Type (2019-2024)
3 Dermatology Drug Market by Application
3.1 Type Introduction
3.1.1 Psoriasis
3.1.2 Skin Infections
3.1.3 Acne
3.1.4 Dermatitis
3.1.5 Others
3.2 Global Dermatology Drug Market Size by Application
3.2.1 Global Dermatology Drug Market Size Overview by Application (2019-2030)
3.2.2 Global Dermatology Drug Historic Market Size Review by Application (2019-2024)
3.2.3 Global Dermatology Drug Market Size Forecasted by Application (2025-2030)
3.3 Global Dermatology Drug Market Size by Regions
3.3.1 North America Dermatology Drug Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Dermatology Drug Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Dermatology Drug Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Dermatology Drug Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Dermatology Drug Market Size Breakdown by Application (2019-2024)
4 Global Market Dynamics
4.1 Dermatology Drug Industry Trends
4.2 Dermatology Drug Industry Drivers
4.3 Dermatology Drug Industry Opportunities and Challenges
4.4 Dermatology Drug Industry Restraints
5 Competitive Insights by Company
5.1 Global Top Players by Dermatology Drug Revenue (2019-2024)
5.2 Global Dermatology Drug Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Dermatology Drug Key Company Headquarters & Area Served
5.4 Global Dermatology Drug Company, Product Type & Application
5.5 Global Dermatology Drug Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Dermatology Drug Market CR5 and HHI
5.6.2 Global Top 5 and 10 Dermatology Drug Players Market Share by Revenue in 2023
5.6.3 2023 Dermatology Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
6.1 AbbVie
6.1.1 AbbVie Comapny Information
6.1.2 AbbVie Business Overview
6.1.3 AbbVie Dermatology Drug Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 AbbVie Dermatology Drug Product Portfolio
6.1.5 AbbVie Recent Developments
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Comapny Information
6.2.2 Johnson & Johnson Business Overview
6.2.3 Johnson & Johnson Dermatology Drug Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Johnson & Johnson Dermatology Drug Product Portfolio
6.2.5 Johnson & Johnson Recent Developments
6.3 Bayer
6.3.1 Bayer Comapny Information
6.3.2 Bayer Business Overview
6.3.3 Bayer Dermatology Drug Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Bayer Dermatology Drug Product Portfolio
6.3.5 Bayer Recent Developments
6.4 Galderma
6.4.1 Galderma Comapny Information
6.4.2 Galderma Business Overview
6.4.3 Galderma Dermatology Drug Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Galderma Dermatology Drug Product Portfolio
6.4.5 Galderma Recent Developments
6.5 Bristol-Myers Squibb
6.5.1 Bristol-Myers Squibb Comapny Information
6.5.2 Bristol-Myers Squibb Business Overview
6.5.3 Bristol-Myers Squibb Dermatology Drug Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Bristol-Myers Squibb Dermatology Drug Product Portfolio
6.5.5 Bristol-Myers Squibb Recent Developments
6.6 Novartis
6.6.1 Novartis Comapny Information
6.6.2 Novartis Business Overview
6.6.3 Novartis Dermatology Drug Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Novartis Dermatology Drug Product Portfolio
6.6.5 Novartis Recent Developments
6.7 Pfizer
6.7.1 Pfizer Comapny Information
6.7.2 Pfizer Business Overview
6.7.3 Pfizer Dermatology Drug Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Pfizer Dermatology Drug Product Portfolio
6.7.5 Pfizer Recent Developments
6.8 Merz Pharma
6.8.1 Merz Pharma Comapny Information
6.8.2 Merz Pharma Business Overview
6.8.3 Merz Pharma Dermatology Drug Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 Merz Pharma Dermatology Drug Product Portfolio
6.8.5 Merz Pharma Recent Developments
6.9 Valeant
6.9.1 Valeant Comapny Information
6.9.2 Valeant Business Overview
6.9.3 Valeant Dermatology Drug Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Valeant Dermatology Drug Product Portfolio
6.9.5 Valeant Recent Developments
6.10 LEO Pharma
6.10.1 LEO Pharma Comapny Information
6.10.2 LEO Pharma Business Overview
6.10.3 LEO Pharma Dermatology Drug Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 LEO Pharma Dermatology Drug Product Portfolio
6.10.5 LEO Pharma Recent Developments
6.11 GlaxoSmithKline
6.11.1 GlaxoSmithKline Comapny Information
6.11.2 GlaxoSmithKline Business Overview
6.11.3 GlaxoSmithKline Dermatology Drug Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 GlaxoSmithKline Dermatology Drug Product Portfolio
6.11.5 GlaxoSmithKline Recent Developments
7 North America
7.1 North America Dermatology Drug Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Dermatology Drug Market Size by Country (2019-2024)
7.3 North America Dermatology Drug Market Size Forecast by Country (2025-2030)
8 Europe
8.1 Europe Dermatology Drug Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Dermatology Drug Market Size by Country (2019-2024)
8.3 Europe Dermatology Drug Market Size Forecast by Country (2025-2030)
9 Asia-Pacific
9.1 Asia-Pacific Dermatology Drug Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Dermatology Drug Market Size by Country (2019-2024)
9.3 Asia-Pacific Dermatology Drug Market Size Forecast by Country (2025-2030)
10 Latin America
10.1 Latin America Dermatology Drug Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Dermatology Drug Market Size by Country (2019-2024)
10.3 Latin America Dermatology Drug Market Size Forecast by Country (2025-2030)
11 Middle East & Africa
11.1 Middle East & Africa Dermatology Drug Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Dermatology Drug Market Size by Country (2019-2024)
11.3 Middle East & Africa Dermatology Drug Market Size Forecast by Country (2025-2030)
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings